Mereo BioPharma Group plc
MREO
$0.32
$0.013.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.71M | -41.88M | -41.57M | -49.55M | -47.19M |
| Total Depreciation and Amortization | 1.18M | 1.15M | 831.00K | 1.12M | 1.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.10M | 12.96M | 8.13M | 17.39M | 12.31M |
| Change in Net Operating Assets | -528.00K | -3.20M | -100.00K | -1.88M | 623.00K |
| Cash from Operations | -26.95M | -30.97M | -32.71M | -32.92M | -33.17M |
| Capital Expenditure | 0.00 | -20.00K | -20.00K | -20.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -300.00K | -299.00K |
| Cash from Investing | 0.00 | -20.00K | -20.00K | -320.00K | -319.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 39.00K | 526.00K | 487.00K | 487.00K | 47.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -134.00K | -199.00K | -239.00K | -833.00K | -918.00K |
| Cash from Financing | -95.00K | 327.00K | 248.00K | -346.00K | 46.57M |
| Foreign Exchange rate Adjustments | 789.00K | 1.85M | 657.00K | 2.28M | 745.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.26M | -28.81M | -31.82M | -31.31M | 13.82M |